also generated GPC3-redirected CCL19-IL-7 CAR-Ts and reported that these cell exhibited improved proliferation and migration functionality according to in vitro assessments and more advanced antitumor activity in hepatocellular carcinoma (HCC) and pancreatic carcinoma cell line-established xenograft models (156). This evidence concerns the gene IL7 and hepatocellular carcinoma.